Intravenous Busulfan Plus Melphalan: An Effective, Chemotherapy-only Transplant Conditioning Regimen in Patients with Acute Lymphoblastic Leukemia

We investigated the administration of intravenous (i.v.) busulfan (Bu) combined with melphalan (Mel) in patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic hematopoietic stem cell transplantation (SCT). Forty-seven patients with median age 33 years (range 20–61) received a matched...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Bone Marrow Transplant
Auteurs principaux: Kebriaei, P, Madden, T, Wang, X, Thall, PF, Ledesma, C, de Lima, M, Shpall, EJ, Hosing, C, Qazilbash, M, Popat, U, Alousi, A, Nieto, Y, Champlin, RE, Jones, RB, Andersson, BS
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4346146/
https://ncbi.nlm.nih.gov/pubmed/22732703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2012.114
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires